PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer

Xueting Ren,Hanxiao Cui,Luyao Dai,Lidan Chang,Dandan Liu,Wenyu Yan,Xuyan Zhao,Huafeng Kang,Xiaobin Ma

DOI: https://doi.org/10.1007/s00432-024-05626-4

2024-03-12

Journal of Cancer Research and Clinical Oncology

Abstract:Gene mutations drive tumor immune microenvironment (TIME) heterogeneity, in turn affecting prognosis and immunotherapy efficacy. PIK3CA is the most frequently mutated gene in breast cancer (BC), yet its relevance to BC prognosis remains controversial. Herein, we sought to determine the impact of PIK3CA mutation-driven immune genes (PDIGs) on BC prognosis in relation to TIME heterogeneity.

oncology